GN Media

Skip to content

Home Services Guides Contact

Breaking blockchain, crypto, tech, and finance news daily! Follow and stay ahead.

gnmedia@gnclubventures.com

CompanyAbout Short Guides Privacy Terms

Part of GN Club VenturesMazal GN Ventures GN Labs GN Club GN Media

Follow

© 2026 GN Media. All rights reserved.

NEWS. INSIGHTS. FUTURE.

Breaking blockchain, crypto, tech, and finance news daily! Follow and stay ahead.

gnmedia@gnclubventures.com

CompanyAbout Short Guides Privacy Terms

Part of GN Club VenturesMazal GN Ventures GN Labs GN Club GN Media

Follow

© 2026 GN Media. All rights reserved.

NEWS. INSIGHTS. FUTURE.

Novo Nordisk’s stock tumbles as doubts persist about Ozempic maker’s strategy | GN Media

financeMarketWatch

Novo Nordisk’s stock tumbles as doubts persist about Ozempic maker’s strategy

September 21, 2026

The drugmaker, best known for developing weight-loss and diabetes drugs, failed to excite investors hoping for a turnaround.

GN Media aggregates headlines — read the full story on MarketWatch.

Read full story on MarketWatch